The document discusses plans to establish a Community Interest Company (CIC) in Staffordshire, England to improve public engagement and involvement in local health and social care services. The CIC would bring together various public engagement functions currently spread across multiple organizations, including public consultation, complaints handling, and collecting consumer insights. It is hoped that a centralized CIC would enhance community engagement, provide commissioners with a shared intelligence resource on public perspectives, and create efficiencies by preventing duplicated efforts. The CIC is intended to take over the local LINk and eventually HealthWatch England responsibilities. Timelines for establishing the CIC and starting trading are provided.
This presentation looks at commissioning for social value: an interim report produced for the Children’s Partnership in March 2014.
For more information on commissioning for social value: http://blogs.ncvo.org.uk/2014/04/07/top-tips-on-commissioning-for-social-value/
JCHR Independent Living Inquiry visit to ecdp, 8 Sept 2011Rich Watts
As part of its Inquiry into Independent Living, the Joint Committee on Human Rights is visiting ecdp tomorrow. Here is our presentation for the visit, which will form one part of the day. The other is the perspectives of 2 of ecdp's members.
Failing to care 12 may 2015 NFWI ResolutionHelen Tyrrell
Failing to care- assessment of need in long term care
This meeting calls on HM government to remove the distinction between health care and social care in the assessment of the needs of individuals, in order to advance health and wellbeing - North Duffield, WI, North Yorkshire East federation
This presentation looks at commissioning for social value: an interim report produced for the Children’s Partnership in March 2014.
For more information on commissioning for social value: http://blogs.ncvo.org.uk/2014/04/07/top-tips-on-commissioning-for-social-value/
JCHR Independent Living Inquiry visit to ecdp, 8 Sept 2011Rich Watts
As part of its Inquiry into Independent Living, the Joint Committee on Human Rights is visiting ecdp tomorrow. Here is our presentation for the visit, which will form one part of the day. The other is the perspectives of 2 of ecdp's members.
Failing to care 12 may 2015 NFWI ResolutionHelen Tyrrell
Failing to care- assessment of need in long term care
This meeting calls on HM government to remove the distinction between health care and social care in the assessment of the needs of individuals, in order to advance health and wellbeing - North Duffield, WI, North Yorkshire East federation
The presentation analyses the open data movement across the world and in India. The current experiments in benchmarking open data initiatives are also briefly mentioned.
ECDP recently took part in OPM's personalisation debate, centring around the importance of frontline workers in social care. This speech represents our argument against the motion.
Blandin Foundation Project: an Application for Sustainable BroadbandAnn Treacy
The Blandin Foundation talks about their ARRA broadband stimulus fund application to the TISP (Telecommunications and Information Society Policy) Forum
Presentation by Chris Asquini; Acting Executive Director, Disability Services - Division DHS at field's 'The great debate - has life improved for people with a disability'.
Forum was held on Wednesday 23 September 2009,
Further information www.field.org.au
LACIE: KC Digital Drive September 2020 Health Innovation TeamKC Digital Drive
Mike Dittemore from LACIE offers an update on operations and industry outlook, concentrating on the organization's new sustainability model, augmented service agreement with the Tiger Institute, and eHealth Exchange.
De presentatie die Gert Urhahn gehouden heeft over zijn manifest "De Spontane Stad" op maandagavond 27 juni 2011 in Architectencafe Utrecht. Zie ook www.architectencafe.nl
The presentation analyses the open data movement across the world and in India. The current experiments in benchmarking open data initiatives are also briefly mentioned.
ECDP recently took part in OPM's personalisation debate, centring around the importance of frontline workers in social care. This speech represents our argument against the motion.
Blandin Foundation Project: an Application for Sustainable BroadbandAnn Treacy
The Blandin Foundation talks about their ARRA broadband stimulus fund application to the TISP (Telecommunications and Information Society Policy) Forum
Presentation by Chris Asquini; Acting Executive Director, Disability Services - Division DHS at field's 'The great debate - has life improved for people with a disability'.
Forum was held on Wednesday 23 September 2009,
Further information www.field.org.au
LACIE: KC Digital Drive September 2020 Health Innovation TeamKC Digital Drive
Mike Dittemore from LACIE offers an update on operations and industry outlook, concentrating on the organization's new sustainability model, augmented service agreement with the Tiger Institute, and eHealth Exchange.
De presentatie die Gert Urhahn gehouden heeft over zijn manifest "De Spontane Stad" op maandagavond 27 juni 2011 in Architectencafe Utrecht. Zie ook www.architectencafe.nl
Architectencafe Utrecht 31 oktober 2011: presentatie Dynamisch Stedelijk Mast...JanWijnand
Presentatie gegeven op 31 oktober 2011 in het Architectencafe Utrecht verzorgd door Herard Roelevink van Bureau Dolte en Ton Baetens van Politiek Online
Haydn Jones (SEQOL) presentation, Doing Different Things conference, December...Wales Co-operative Centre
This presentation was used during a workshop at the Doing Different Things conference, held on 4th December 2014. The conference looked into the role of social enterprises, co-operatives and other Third Sector organisations in the delivery of social care and wellbeing services in Wales. The event was run by Welsh Government, Wales Co-operative Centre and Social Firms Wales.
Joint Strategic Commissioning is at the heart of the Public Bodies (Joint Working) Bill. JIT has recently issued guidance on what Partnerships need to do in order to develop Strategic Plans that incorporate a Financial Plan, relating to all integrated resources, by April 2015. This session provides an opportunity to further explore the scale and scope of what partnerships are required to do to deliver on the opportunities and ambitions of integrated health and social care. Contributed by: Joint Improvement Team
Presentation at the Thriving VCF Leadership Group Event on 1 May 2014. The event focussed on the first workstream of the Integrated Commissioning work programme of the Health and Wellbeing Board. For more information, see https://www.sheffield.gov.uk/caresupport/health/health-wellbeing-board/integration.html.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
![Background ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)